|
|
Thomson Financial Business Description:
| The principal activity of the Group is developing products for diagnosis, prevention and treatment of allergies. The Group operates through one business area namely: Allergy sector. The Allergy sector operates within allergy vaccination - injection-based and drop-based vaccines, the only treatment able to cure allergy rather than just alleviate symptoms. In addition to the existing business, the Group has developed a pipeline of projects which have the potential to bring crucial, innovative change to the treatment and cure of allergy. The Group operates subsidiaries in France, Netherlands, Italy, Sweden, Germany, UK and USA, and has sales offices in China, Finland, Norway and Denmark. In fiscal 2006 the Group introduced the new vaccine GRAZAX on the market. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on ALK-Abello AS
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
